BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027 KT-621 BREADTH Phase 2b trial in asthma ongoing, with data expected in late-2027 Initiated dosing in KT-579 ...
The City of Pattaya continues to push ahead with improvements to the Railway Parallel Road, from Khao Talo to the Wat Tham ...
The paramilitary commander wants to turn battlefield control into political recognition, but genocide findings, sanctions and ...
Streamlining of selected non‑strategic early-stage programs completed, consistent with previously announced three-year ...
From November 30, 2024 to November 30, 2025, Kenya’s Chairmanship of the East African Community (EAC) unfolded as a defining ...
At MWC Barcelona 2026, Huawei debuts its latest SuperPoD product Atlas 950 SuperPoD, TaiShan 950 SuperPoD and a series of ...
Bezel’s website breaks down the brands its data identify as being the most subject to counterfeiting. Rolex accounts for ...
Against this backdrop, the 11 th chairman of Sebi, Tuhin Kanta Pandey, has done a phenomenally outstanding job in his one ...
The company managing the Bucharest subway network, Metrorex, has plans for the extension of the underground connections, with ...
The Prime Minister of the Government of National Unity, Abdul Hamid Dbeibah, said that a unified development agreement is the ...
David O'Connor P.Geo., Chief Geologist for AbraSilver, is the Qualified Person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, and he has reviewed and approved ...
Gothenburg, February 27, 2026 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next-generation cancer treatments based on its proprietary iTANK platform, tod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results